Gilliland et al. [15] reported a pediatric case of NASH secondary to panhypopituitarism from craniopharyngioma and found that GH replacement therapy led to rapid and complete resolution of hepatic steatosis. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatohepatitis.